VJHemOnc is committed to improving our service to you

MDS 2020 | Update on treatments for high- and low-risk MDS

VJHemOnc is committed to improving our service to you

Nicolas Bonadies

Nicolas Bonadies, MD, Bern University Hospital, Bern, Switzerland, discusses the latest advancements in treatments for both low-risk and high-risk myelodysplastic syndromes (MDS). This interview took place at the 2nd Regional Symposium on Myelodysplastic Syndromes (MDS 2020), held in Tel Aviv, Israel.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter